Remedent Announces Fifth GlamSmile Studio in China
April 30 2013 - 12:09PM
Marketwired
Remedent, Inc. (OTCBB: REMI), an international company specializing
in research, development, and manufacturing of oral care and
cosmetic dentistry products, announces that construction works are
under way for the fifth GlamSmile Studio in China. Following the
GlamSmile Studio's in Beijing, Shanghai, Wenzhou and Hong Kong,
a new 600 m² / 6,453 ft² Studio in Guangzhou with
6 operational chairs is planned to open in the next quarter in
the prestigious Guangzhou International Trading Building in CBD
Area.
Guangzhou -- known historically as Canton -- is the third
largest Chinese city with a little over 13 million people. It is a
key national transportation hub and trading port, located 120 km
northwest of Hong Kong and northeast of Macau.
Management Commentary: "Pursuant to our
Chinese bus plan and encouraged by yet another record quarter in
China this opening in Guanzhou is very important in our strategy,"
comments Mr Guy De Vreese, CEO of Remedent. "It is our biggest most
luxurious store to date with 6 chairs."
About Remedent: Remedent Inc. creates
state-of-the-art dental technologies and marketing concepts. Famous
brands are GlamSmile, Remecure, White Boost, Formulation +, and
River 8. Headquartered in Belgium, Remedent Inc. manufactures,
markets and distributes its products and concepts to more than 25
countries worldwide. Remedent Inc. is publicly listed and focuses
on B2B, delivering products to the dental professional, as well as
B2C approaches, helping consumers to obtain their dream smile
through its Smile Consultancy Concept.
Statement under the Private Securities
Litigation Reform Act of 1995 Statements in this press release
that are "forward-looking statements" are based on current
expectations and assumptions that are subject to risks and
uncertainties. Such forward-looking statements involve known and
unknown risks, uncertainties and other unknown factors that could
cause Remedent's actual operating results to be materially
different from any historical results or from any future results
expressed or implied by such forward-looking statements. In
addition to statements that explicitly describe these risks and
uncertainties, readers are urged to consider statements that
contain terms such as "believes," "belief," "expects," "expect,"
"intends," "intend," "anticipate," "anticipates," "plans," "plan,"
"projects," "project," to be uncertain and forward-looking. Actual
results could differ materially because of factors such as
Remedent's ability to achieve the synergies and value creation
contemplated by the proposed transaction. For further information
regarding risks and uncertainties associated with Remedent's
business, please refer to the risk factors described in Remedent's
filings with the Securities and Exchange Commission, including, but
not limited to, its annual report on Form 10-K and quarterly
reports on Form 10-Q.
For more info, please contact: Mr Luc Maes Marketing
Manager Remedent Zuiderlaan 1-3 box 8, 9000 Gent - Belgium T:
+32-9-2415880 E: info@remedent.com W: www.remedent.com
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jul 2023 to Jul 2024